Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: AB Foods Reports Sales Rises Across Portfolio

Thu, 16th Jan 2020 08:03

(Alliance News) - Associated British Foods highlighted a string of trading updates from UK consumer companies on Thursday.

AB Foods said its outlook is unchanged following a good first quarter for fast fashion store chain Primark.

Group sales for the 16 weeks to January 4 were up 4% year-on-year at constant currency, and 3% ahead at actual rates.

Sales at high-street chain Primark were up 4.5% year-on-year at constant currency and 3.0% ahead at actual exchange rates. This was, however, "almost entirely" driven by an increase in selling space. The like-for-like performance improved, AB Foods said without specifying numbers, driven by a marked upturn in the eurozone.

In the UK, Primark sales were up 4.0% driven by new selling space and a "marginal" decline in like-for-like sales. Sales in the eurozone were up 5.1% with the improvement in like-for-like sales seen in the final quarter of the previous financial year continuing. The US also delivered like-for-like sales growth.

"As expected, operating profit margin in the period decreased, with the effect of purchases contracted at a stronger US dollar exchange rate than last year but partially mitigated by cost reductions in both the cost of goods and overheads," said AB Foods.

In the current financial year, AB Foods expects to open 18 new Primark stores, with its first store in eastern Europe, in Ljubljana, Slovenia exceeding expectations.

Elsewhere in the AB Foods portfolio, Sugar revenue was up 7% at constant currency and Grocery sales flat, while Agriculture revenue was 10% ahead of a year ago and Ingredients sales up 3%.

The stock was up 2.1% in early dealings Thursday.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: up 3.52 points at 7,646.32

----------

Hang Seng: up 0.2% at 28,824.69

Nikkei 225: closed up 0.1% at 23,933.13

DJIA: closed up 90.55 points, 0.3%, at 29,030.22

S&P 500: closed up 0.2% at 3,289.29

----------

GBP: firm at USD1.3039 (USD1.3024)

EUR: soft at USD1.1147 (USD1.1159)

Gold: up at USD1,552.91 per ounce (USD1,549.30)

Oil (Brent): up at USD64.34 a barrel (USD63.70)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Thursday's Key Economic Events still to come

0930 GMT UK Bank of England credit conditions survey

1000 CET France IEA oil market report

0830 EST US import and export price indices

0830 EST US advance monthly sales for retail & food services

0830 EST US initial jobless claims

1000 EST US manufacturing & trade: inventories & sales

1000 EST US NAHB housing market index

1030 EST US EIA weekly natural gas storage report

----------

The UK property market has been given a lift by the general election result, according to surveyors. The number of house sales taking place across the UK has increased for the first time in seven months, the Royal Institution of Chartered Surveyors report for December said. Agreed sales in London and East Anglia in particular saw an improvement, although sales reportedly weakened in Northern Ireland and Scotland. Inquiries from buyers are also now generally on the up, after previously falling back in November, the report found.

----------

Consumer prices in Germany rose by 1.4% on an average annual basis in 2019, the Federal Statistical Office of Germany said. The average year-on-year increase in 2019 was down on the 1.8% average rise seen in 2018. The deceleration was attributed to a marked slowdown in energy price inflation to 1.4% in 2019 from 4.6% in 2018. Turning to December, the annual German consumer price inflation rate was 1.5%, accelerating from 1.1% in November. December's reading marked the first acceleration since July.

----------

BROKER RATING CHANGES

----------

BARCLAYS CUTS GLAXOSMITHKLINE TO 'UNDERWEIGHT' (EQUAL WEIGHT) - PRICE TARGET 1650 PENCE

----------

JEFFERIES CUTS DIAGEO TO 'HOLD' (BUY) - PRICE TARGET 3600 PENCE

----------

BARCLAYS CUTS SPIRENT TO 'UNDERWEIGHT' ('EQUAL WEIGHT') - TARGET 190 (159) PENCE

----------

COMPANIES - FTSE 100

----------

Pearson said it met guidance in 2019 though predicts challenging trends in US Higher Education Courseware to continue. The educational publisher said underlying revenue was flat in 2019 and adjusted operating profit GBP590 million. US Higher Education Courseware revenue declined by 12%, though there was "modest" growth in digital revenue. Pearson said it expects the trends seen in the unit to continue, with heavy declines in print partially offset by modest growth in digital. For 2020, Pearson expects to deliver adjusted operating profit between GBP500 million to GBP580 million, including the 25% stake in Penguin Random House that it recently agreed to sell for USD675 million. Pearson said Chief Financial Officer Coram Williams will be leaving the company and will be replaced by Sally Johnson, deputy financial officer. Williams will step down from his position and from the board later this year.

----------

Whitbread said it delivered a "robust" third quarter despite challenging conditions in the UK. Total UK sales in the third quarter were up 0.3%, though fell 1.3% on a like-for-like basis. UK & International total sales growth was 1.0%. The start of the fourth quarter has seen more positive regional UK data due to lower comparators and the timing of Christmas, the company said, along with the continuation of the strong London market. However, "it is still early" in the fourth quarter and "a level of caution" remains on the UK hotel environment, Whitbread added. Looking into the 2021 financial year, Whitbread noted that the UK backdrop remains "uncertain" and sustained industry inflation continues. Whitbread said it will take a cautious approach to hotel demand and expects a net margin headwind of around GBP60 million, comprising wage inflation and ongoing investment, partially offset by its efficient programme.

----------

COMPANIES - FTSE 250

----------

Recruitment firm Hays expects a fall in first half revenue due to strikes in France, the bushfires in Australia, the UK general election, and a slowdown in activity in Germany. Hays said it expects operating profit for the first half of around GBP100 million, which would be down from GBP124.1 million a year ago. Group net fees for the second quarter, which ended December 31, fell by 7% on a headline basis and 4% like-for-like. Like-for-like net fees in its Temp and Perm businesses declined by 3% and 6% respectively. In Australia & New Zealand, net fees were down 7% like-for-like and Germany down 9%, while the UK & Ireland fell 4%.

----------

COMPANIES - OTHER MAIN MARKET AND AIM

----------

Seawave Investment - the firm which, according to Lekoil, brokered a loan to the Nigerian oil firm from fake Qatari investors - will address the matter, the Financial Times reported. Lekoil late Monday said it parted, "in good faith" with USD600,000 to Seawave which acted as an introducer to those "purporting to be the Qatar Investment Authority". At the start of January, Lekoil announced it agreed a USD184.0 million loan from QIA for drilling and development at the Ogo field off the coast of Nigeria. Seawave's Managing Partner Bismarck Abrafi told the newspaper that the company will respond to the allegations. "We will issue a full statement and everything will be clear," Abrafi told the FT.

----------

COMPANIES - INTERNATIONAL

----------

The Japanese lawyer nicknamed the "Razor" who was spearheading Carlos Ghosn's defence said Thursday he is quitting the case after his client skipped bail and fled Japan for Lebanon. Junichiro Hironaka's office issued a brief statement saying they had "filed with the Tokyo District Court letters of resignation for all lawyers...connected with all cases related to Carlos Ghosn". Hironaka, 74, who earned his nickname for sharp legal strategies and an enviable acquittal record, has said he was "dumbfounded" by Ghosn's escape, which he discovered via the media on the morning his client fled. Another one of Ghosn's legal team, Takashi Takano, has also thrown in the towel on the case, a source close to his office told AFP.

----------

Thursday's Shareholder Meetings

Cardiff Property

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.